Abstract:Abstract Background Improved outcome prediction in individuals at high risk for psychosis may facilitate targeted early intervention. Studies suggest that improved outcome prediction may be achieved through the use of neurocognitive or neuroimaging data, on their own or in addition to clinical data. This study examines whether adding resting-state functional connectivity data to validated clinical predictors of psychosis improve outcome prediction in the prodromal stage. Methods This study involves 137 adolescents and young adults at Clinical High Risk (CHR) for psychosis from the Shanghai At Risk for Psychosis (SHARP) program. Based on outcome after one-year follow-up, participants were separated into three outcome categories: good outcome (symptom remission, N = 71), intermediate outcome (ongoing CHR symptoms, N = 30), and poor outcome (conversion to psychosis or treatment-refractory, N = 36). Resting-state fMRI data were acquired for each participant and processed using the Conn toolbox, including rigorous motion correction. Multinomial logistic regression analysis and leave-one-out cross-validation were used to assess the performance of three prediction models: 1) a clinical-only model using validated clinical predictors from the NAPLS-2 psychosis-risk calculator, 2) an fMRI-only model using measures of functional connectome organization and within/between-network connectivity among established resting-state networks, and 3) a combined clinical and fMRI prediction model. Model performance was assessed using the harmonic mean of the positive predictive value and sensitivity for each outcome category. This F1 measure was compared to expected chance-levels using a permutation test with 1,000 sampled permutations in order to evaluate the statistical significance of the model’s prediction. Results The clinical-only prediction model failed to achieve a significant level of outcome prediction (F1 = 0.32, F1-chance = 0.26 □ 0.06, p = .154). The fMRI-only model did predict clinical outcome to a significant degree (F1 = 0.41, F1-chance = 0.29 □ 0.06, p = .016), but the combined clinical and fMRI prediction model showed the best performance (F1 = 0.46, F1-chance = 0.29 □ 0.06, p < .001). On average, positive predictive values (reflecting the probability that an outcome label predicted by the model was correct) were 39% better than chance-level and 32% better than the clinical-only model. Analyzing the contribution of individual predictor variables showed that GAF functional decline, a family history of psychosis, and performance on the Hopkins Verbal Learning Test were the most influential clinical predictors, whereas modular connectome organization, default-mode and fronto-parietal within-network connectivity, and between-network connectivity among language, salience, dorsal attention, cerebellum, and sensorimotor networks were the leading fMRI predictors. Discussion This study’s findings suggest that functional brain abnormalities reflected by alterations in resting-state functional connectivity precede and may drive subsequent changes in clinical functioning. Moreover, the findings show that markers of functional brain connectivity may be useful for improving early identification and clinical decision-making in prodromal psychosis.

Transcriptional and neurochemical signatures of cerebral blood flow alterations in schizophrenia and the clinical high-risk state for psychosis

Decreased Regional Homogeneity and Increased Functional Connectivity of Default Network Correlated with Neurocognitive Deficits in Subjects with Genetic High-Risk for Schizophrenia: A Resting-State Fmri Study.

Epigenetic Clock Analysis of Blood Samples in Drug-Naive First-Episode Schizophrenia Patients.

Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder

Functional connectivity in people at clinical and familial high risk for schizophrenia

The Role of Altered Brain Structural Connectivity in Resilience, Vulnerability, and Disease Expression to Schizophrenia.

Brain functional connectivity data enhance prediction of clinical outcome in youth at risk for psychosis.

T14. FUNCTIONAL AND STRUCTURAL CONNECTIVITY IN SUBJECTS AT HIGH RISK FOR PSYCHOSIS AS A POSSIBLE BIOMARKER FOR THEIR TRANSITION TO SCHIZOPHRENIA – A COMBINED EEG AND DTI STUDY

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia

Schizophrenia Imaging Signatures and Their Associations with Cognition, Psychopathology, and Genetics in the General Population.

Molecular and micro-architectural mapping of gray matter alterations in psychosis

Dynamic functional connectivity impairments in early schizophrenia and clinical high-risk for psychosis.

Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis

Altering the course of schizophrenia: progress and perspectives

Evidence of Discontinuity Between Psychosis-Risk and Non-Clinical Samples in the Neuroanatomical Correlates of Social Function.

Functional brain connectivity data improve clinical outcome prediction in youth at risk for psychosis

Spatiotemporal Dynamics of Functional Connectivity and Association with Molecular Architecture in Schizophrenia.

Peripheral Transcriptome of Clinical High-Risk Psychosis Reflects Symptom Alteration and Helps Prognosis Prediction.

A Framework for Linking Resting-State Chronnectome/genome Features in Schizophrenia: A Pilot Study

Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions

Probing the Biological Underpinnings of Advanced Brain Ageing in Schizophrenia